Table of Content

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Imaging Clinical Research Organization (CRO) Market
5. Voice of Customer
6. Global Imaging Clinical Research Organization (CRO) Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Services Offered (Imaging Acquisition and Protocol Development, Application Design, Image Collection and Quality Control, Digital Image Conversion, Support and Maintenance, Others)
6.2.2. By Imaging Modality (Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Others)
6.2.3. By Clinical Trial Phase (Phase 1, Phase 2, Phase 3)
6.2.4. By Application (Oncology, Neurology, Cardiovascular, Ophthalmology, Others)
6.2.5. By End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic & Research Institutions, Others)
6.2.6. By Region
6.2.7. By Company (2021)
6.3. Market Map
7. North America Imaging Clinical Research Organization (CRO) Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Services Offered
7.2.2. By Imaging Modality
7.2.3. By Clinical Trial Phase
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. North America: Country Analysis
7.3.1. United States Imaging Clinical Research Organization (CRO) Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Services Offered
7.3.1.2.2. By Imaging Modality
7.3.1.2.3. By Clinical Trial Phase
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. Canada Imaging Clinical Research Organization (CRO) Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Services Offered
7.3.2.2.2. By Imaging Modality
7.3.2.2.3. By Clinical Trial Phase
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. Mexico Imaging Clinical Research Organization (CRO) Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Services Offered
7.3.3.2.2. By Imaging Modality
7.3.3.2.3. By Clinical Trial Phase
7.3.3.2.4. By Application
7.3.3.2.5. By End User
8. Europe Imaging Clinical Research Organization (CRO) Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Services Offered
8.2.2. By Imaging Modality
8.2.3. By Clinical Trial Phase
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. France Imaging Clinical Research Organization (CRO) Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Services Offered
8.3.1.2.2. By Imaging Modality
8.3.1.2.3. By Clinical Trial Phase
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. Germany Imaging Clinical Research Organization (CRO) Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Services Offered
8.3.2.2.2. By Imaging Modality
8.3.2.2.3. By Clinical Trial Phase
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. United Kingdom Imaging Clinical Research Organization (CRO) Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Services Offered
8.3.3.2.2. By Imaging Modality
8.3.3.2.3. By Clinical Trial Phase
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. Italy Imaging Clinical Research Organization (CRO) Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Services Offered
8.3.4.2.2. By Imaging Modality
8.3.4.2.3. By Clinical Trial Phase
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Spain Imaging Clinical Research Organization (CRO) Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Services Offered
8.3.5.2.2. By Imaging Modality
8.3.5.2.3. By Clinical Trial Phase
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. Asia-Pacific Imaging Clinical Research Organization (CRO) Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Services Offered
9.2.2. By Imaging Modality
9.2.3. By Clinical Trial Phase
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Imaging Clinical Research Organization (CRO) Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Services Offered
9.3.1.2.2. By Imaging Modality
9.3.1.2.3. By Clinical Trial Phase
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. India Imaging Clinical Research Organization (CRO) Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Services Offered
9.3.2.2.2. By Imaging Modality
9.3.2.2.3. By Clinical Trial Phase
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Japan Imaging Clinical Research Organization (CRO) Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Services Offered
9.3.3.2.2. By Imaging Modality
9.3.3.2.3. By Clinical Trial Phase
9.3.3.2.4. By Application
9.3.3.2.5. By End User
9.3.4. South Korea Imaging Clinical Research Organization (CRO) Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Services Offered
9.3.4.2.2. By Imaging Modality
9.3.4.2.3. By Clinical Trial Phase
9.3.4.2.4. By Application
9.3.4.2.5. By End User
9.3.5. Australia Imaging Clinical Research Organization (CRO) Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Services Offered
9.3.5.2.2. By Imaging Modality
9.3.5.2.3. By Clinical Trial Phase
9.3.5.2.4. By Application
9.3.5.2.5. By End User
10. South America Imaging Clinical Research Organization (CRO) Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Services Offered
10.2.2. By Imaging Modality
10.2.3. By Clinical Trial Phase
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Imaging Clinical Research Organization (CRO) Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Services Offered
10.3.1.2.2. By Imaging Modality
10.3.1.2.3. By Clinical Trial Phase
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Argentina Imaging Clinical Research Organization (CRO) Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Services Offered
10.3.2.2.2. By Imaging Modality
10.3.2.2.3. By Clinical Trial Phase
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. Colombia Imaging Clinical Research Organization (CRO) Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Services Offered
10.3.3.2.2. By Imaging Modality
10.3.3.2.3. By Clinical Trial Phase
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Middle East and Africa Imaging Clinical Research Organization (CRO) Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Services Offered
11.2.2. By Imaging Modality
11.2.3. By Clinical Trial Phase
11.2.4. By Application
11.2.5. By End User
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Imaging Clinical Research Organization (CRO) Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Services Offered
11.3.1.2.2. By Imaging Modality
11.3.1.2.3. By Clinical Trial Phase
11.3.1.2.4. By Application
11.3.1.2.5. By End User
11.3.2. Saudi Arabia Imaging Clinical Research Organization (CRO) Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Services Offered
11.3.2.2.2. By Imaging Modality
11.3.2.2.3. By Clinical Trial Phase
11.3.2.2.4. By Application
11.3.2.2.5. By End User
11.3.3. UAE Imaging Clinical Research Organization (CRO) Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Services Offered
11.3.3.2.2. By Imaging Modality
11.3.3.2.3. By Clinical Trial Phase
11.3.3.2.4. By Application
11.3.3.2.5. By End User
11.3.4. Turkey Imaging Clinical Research Organization (CRO) Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Services Offered
11.3.4.2.2. By Imaging Modality
11.3.4.2.3. By Clinical Trial Phase
11.3.4.2.4. By Application
11.3.4.2.5. By End User
11.3.5. Egypt Imaging Clinical Research Organization (CRO) Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Services Offered
11.3.5.2.2. By Imaging Modality
11.3.5.2.3. By Clinical Trial Phase
11.3.5.2.4. By Application
11.3.5.2.5. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Laboratory Corporation of America Holdings
14.2. IXICO PLC
14.3. ICON plc
14.4. The Micron Group
14.5. Medpace Holdings, Inc.
14.6. Radiant Sage LLC
14.7. Biomedical Systems Corporation
14.8. Worldcare Clinical, LLC
14.9. Imaging Endpoints LLC
14.10. Parexel International Corporation
15. Strategic Recommendations